Clinical Trials Browser

Phase 3 × OTHER_GOV × Breast × Clear all

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

Breast Neoplasms

NCT07057427 2025-07-09

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT01785420 2025-04-09

Pre Operative Trastuzumab in Operable Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT01916317 2025-04-09

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Phase 3 Active not recruiting

Operable Breast Cancer

NCT03168880 2025-04-09

TNBC

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT04547907 2024-09-20

A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Phase 3 Recruiting

Breast Cancer,HER2-positive

NCT03423199 2024-03-22

PATHWAY

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Phase 3 Withdrawn

Pathologic Complete Response, Breast Neoplasms

NCT05591456 2022-10-25

Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients

Phase 3 Completed

Breast Cancer Radiotherapy

NCT02995772 2019-06-19

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms

NCT00193726 2018-09-20

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

Phase 3 Terminated

Breast Neoplasms

NCT03162276 2018-09-07

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Phase 3 Unknown

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT02865304 2016-08-12

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Phase 3 Unknown

Breast Neoplasms

NCT02525159 2015-08-17

EDIMI216OHE1

Phase 3 Completed

Breast Neoplasms

NCT01501669 2012-07-18

PROCEED

Phase 3 Unknown

Breast Neoplasms

NCT01452672 2011-10-17

Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00896155 2011-08-30

CONSET

Phase 3 Unknown

Breast Neoplasms, Pulmonary Fibrosis

NCT00352378 2011-06-27

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT01116713 2010-05-05

dxt2010brca

Phase 3 Completed

Breast Neoplasms, Pain, Postoperative, Postoperative Nausea and Vomiting